Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Maternal mortality in Switzerland 2005–2014

Original article
Perotto L, Zimmermann R, Quack Lötscher KC
Swiss Med Wkly. 2020;150:w20345

The trend of reducing direct maternal mortality as well as lethality after caesarean section continues. Haemorrhage is still the leading cause of direct maternal mortality. Indirect maternal mortality is increasing and specifically suicides need special attention.

Patiromer and medication optimisation in heart failure with reduced ejection fraction: a Swiss perspective

Review article: Biomedical intelligence
Meyer P, Lu H, Hullin R
Swiss Med Wkly. 2020;150:w20362

Despite medical advances, heart failure remains a major public health issue and is associated with considerable morbidity and mortality. Suboptimal use of evidence-based therapies and lack of medication up-titration play important roles in this regard. Hyperkalaemia is a frequent and potentially harmful finding which hinders treatment optimisation in patients with heart failure. In this review, heart failure experts from two Swiss academic hospitals discuss the principles of general pharmacological therapy in heart failure with reduced ejection fraction and the different treatment options for chronic hyperkalaemia, focusing on patiromer, a recently available potassium binder. 

Incidence of glomerulonephritis in the western part of Switzerland over the last decade

Original article
Nanchen G, Schutzbach K, Rotman S, Winzeler R, Ambühl P, Halfon M, Pruijm M
Swiss Med Wkly. 2020;150:w20353

Glomerulonephritis is a rare yet serious group of diseases with a high risk of progression to end-stage renal disease. For optimal healthcare planning, detailed epidemiological and demographic data are essential.

Use of the wearable cardioverter-defibrillator – the Swiss experience

Original article
Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss WCD Registry
Swiss Med Wkly. 2020;150:w20343

The use of wearable cardioverter defibrillators has increased in Switzerland over the years for a variety of indications. There is high therapy adherence to the WCD, and a treatment rate comparable to previously published registry data.

Long-term evaluation of the distal transverse plantar approach for Morton’s neuroma excision

Original article
Ngo THNN, Traverso A, Chopra S, Hassani H, Crevoisier X
Swiss Med Wkly. 2020;150:w20347

The transverse plantar approach results in good objective outcome scores, including scar healing, in the long term. It offers optimal visualisation of the nerve, does not require deep dissection and allows the exposure of two adjacent web spaces of the foot through a single incision.

2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)

Review article: Medical guidelines
Ferrari S, Lippuner K, Lamy O, Meier C
Swiss Med Wkly. 2020;150:w20352

No specific treatment recommendations have been made so far in our country to guide therapy according to the baseline level of risk. The authors define four risk subgroup categories and propose an algorithm for osteoporosis therapy according to the level of fracture risk.

Candida auris – recommendations on infection prevention and control measures in Switzerland

Review article: Medical guidelines
Vuichard-Gysin D, Sommerstein R, Martischang R, Harbarth S, Kuster SP, Senn L, Widmer A
Swiss Med Wkly. 2020;150:w20297

Candida auris, a globally emerging pathogen, has been repeatedly introduced into European healthcare settings, leading to large and long-lasting nosocomial outbreaks. The pathogen has already been isolated in Switzerland, requiring clinicians and microbiologists to become alert.

Including adolescents of childbearing potential in clinical trials with possible exposure to teratogenic medication: a challenge for paediatricians and researchers

Review article: Medical guidelines
Michaud PA, Diezi M, Guihard L, Jacot-Guillarmod M, Kleist P, Sprumont D, Wenger P
Swiss Med Wkly. 2020;150:w20333

This article reviews how to address practical and ethical questions regarding minor adolescents of childbearing potential enrolled in a clinical trial that may involve teratogenic medication and offers a series of concrete advice and tools for dealing with problematic situations.

Ultrasound-guided regional anaesthesia and reduction of distal radius fractures in an emergency department

Original article
Ammann S, Schoell E, Nieves Ortega R, Bingisser R
Swiss Med Wkly. 2020;150:w20288

The combination of ultrasound-guided regional anaesthesia and ultrasound-guided reduction of distal radius fractures is feasible.  Effectiveness regarding the necessity of subsequent operation was comparable to usual care.

Outcomes after spinal stenosis surgery by type of surgery in adults aged 60 years and older

Original article
Degen T, Fischer K, Theiler R, Schären S, Meyer OW, Wanner G, Chocano-Bedoya P, Simmen HP, Schmid UD, Steurer J, Stähelin HB, Mantegazza N, Bischoff-Ferrari HA
Swiss Med Wkly. 2020;150:w20325

Verpassen Sie keinen Artikel!